SPONSORS

Barcelona Mobile World Capital

The Barcelona Mobile World Capital (BMWC) acts as a meeting point for the main industries, with the mission to help creating optimal conditions to achieve global benchmark for mobile transformation.

Within the BMWC umbrella, mHealth Competence Center (mHCC), is focused on promoting the improvement of the welfare and health of citizens by personalizing services based on mobile technology.

The vision of mHCC is to become a key player in the development of mobile technologies applied to health and welfare by promoting processes acceleration and alignment of stakeholders toward common goals.

Telefónica

Telefónica is one of the largest telecommunications companies in the world in terms of market capitalisation and number of customers. With its best in class mobile, fixed and broadband networks, and an innovative portfolio of digital solutions, Telefónica is transforming itself into a ‘Digital Telco’, a company that will be even better placed to meet the needs of its customers and capture new revenue growth.

Telefónica’s vision is to make the possibilities offered by the new digital world real, and to be one of the leaders in this area. One of the steps the company has taken to get ahead of its competitors is the creation of different global product and service development units, covering, among others: cloud computing, security, financial services, M2M (machine-to-machine connections), video and digital home, applications and e-Health. The purpose of these units is to leverage economies of scale and adapt global developments to regional needs.

The company has a significant presence in 21 countries and a customer base that amounts more than 316.1 million accesses around the world. Telefónica has a strong presence in Spain, Europe and Latin America, where the company focuses an important part of its growth strategy. Our customers identify Telefónica through our commercial brands, of which Movistar, O2 and Vivo are the most well-known. These brands represent our mobile, landline, Internet and television telecommunication services to more than 300 million customers from several countries.

AAL PROGRAMME

The Active and Assistive Living (AAL) programme funds projects in public-private partnership in the field of information and communication technology (ICT) for active and healthy ageing since 2008. The programme was renamed this year after being renewed for a second phase (the first was from 2008 until 2013 and was named ambient assisted living joint programme) and it is financed by the European Commission –under the Horizon 2020umbrella- and 19 countries until 2020 for an estimated budget of € 600 million.

The overall objective of AAL is to enhance the quality of life of older adults while strengthening the industrial base in Europe through the use of ICT. Since 2008, AAL has issued 7 calls for proposals each focusing on a different issues and has funded 154 trans-national innovations projects with over 1000 partners. Almost half of these project partners are small and medium enterprises (SMEs), which are collaborating with user organisations, large enterprises, universities and research organisations in the development of innovative solutions. The AAL projects aim at introducing their solution to the market within 2 to 3 years after the end of the project, aiming at making research in Europe a self-sustainable domain with clear commercialization goals.

Globo

Globo (LSE-AIM:GBO) is an international leader and technology innovator delivering Enterprise Mobility Management and Mobile Application Development solutions. Our GO!Enterprise (EMM) and GO!AppZone (MADP) offerings help businesses expand their engagement with employees and customers through the mobile channel via a secure and extensible environment that runs on all smart devices. The Group operates internationally through subsidiaries and offices in U.S., U.K., Europe, Middle East and South East Asia.

AQuAS

Agencia de Qualitat i Avaluació Sanitaries de Catalunya (AQuAS) (http://aquas.gencat.cat/ca/) has the mission to contribute to the improvement of the quality, safety and sustainability of the Catalan Healthcare System by actively promoting public driven demand innovation through public procurement and is deeply committed to the use of pre-commercial procurement (PCP) and public procurement of innovation (PPI) to achieve its goals in the public Health sector. AQuAS is proud to present 2 Flagship Projects (co-funded by the European Commission) on Innovation Procurement:

DECIPHER (http://www.decipherpcp.eu)– a Pre-commercial procurement procedure for the Solution exploration, Prototyping and Original development of European wide test series of cross-border, mobile, secure and interoperable technologies integrated to access local patient health records. DECIPHER has already awarded phase 1 contracts to 9 technology providers – who will be presented during the MWC.

INSPIRE (http://www.inspirecampus.eu) - a Network of contracting authorities in eHealth, active ageing and independent living that aims to achieve practical impact on the use of PCP and link with venture capital activities. Focus will be on sharing and disseminating evidence on innovation procurement practices from EU projects, and in particular promotion of the risk/benefit sharing aspects of these.

Visit our booth for more information and to discover the opportunities PCP and PPI can offer to the mobile sector!

Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s customised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2012 Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 45.5 billion Swiss francs. Genentech, in the United States, is a wholly-owned member of Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

More information at www.roche.com

Emminens Healthcare Services

Emminens Healthcare Services is a Roche Diagnostics S.L. company based in Madrid providing services to improve the customised care of chronic diseases, with a special focus on diabetes.

Pioneering in the development of e-Health solutions for the past 10 years, the company's R&D is 100% based in Spain and it exports its solutions to foreign markets.

More information at www.emminens.com

Marand

Marand is a solution provider in healthcare offering products including Think!Med Clinical™, Think!EHR Platform and EhrScape.com. Solutions are based on state of the art technology and industry standards such as openEHR, IHE and HL7

Think!EHR Platform is a health data platform based on vendor-neutral open data standards designed for real-time, transactional health data storage, query, retrieve and exchange. It was awarded second prize for "Best eHealth Solution by an EU SME" at HIMSS World of Health IT 2014 in Nice, France and is being used to power solutions in Brazil, Moscow, Norway, Slovenia and Sweden.